EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 390 filers reported holding EXELIXIS INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,202,500 | +10.9% | 650,000 | -3.0% | 0.52% | +8.8% |
Q2 2023 | $12,803,700 | -10.9% | 670,000 | -9.5% | 0.48% | -15.7% |
Q1 2023 | $14,363,400 | -2.7% | 740,000 | -19.6% | 0.57% | -10.6% |
Q4 2022 | $14,756,800 | +13.4% | 920,000 | +10.8% | 0.63% | +9.9% |
Q3 2022 | $13,014,000 | -32.1% | 830,000 | -9.8% | 0.58% | -27.1% |
Q2 2022 | $19,154,000 | -40.5% | 920,000 | -35.2% | 0.79% | -17.5% |
Q1 2022 | $32,191,000 | -8.3% | 1,420,000 | -26.0% | 0.96% | +8.2% |
Q4 2021 | $35,098,000 | -14.9% | 1,920,000 | -1.5% | 0.88% | -18.7% |
Q3 2021 | $41,223,000 | +11.5% | 1,950,000 | -3.9% | 1.09% | +11.2% |
Q2 2021 | $36,987,000 | -33.4% | 2,030,000 | -17.5% | 0.98% | -34.3% |
Q1 2021 | $55,571,000 | +46.5% | 2,460,000 | +30.2% | 1.49% | +50.3% |
Q4 2020 | $37,932,000 | +12.4% | 1,890,000 | +37.0% | 0.99% | -0.4% |
Q3 2020 | $33,741,000 | +19.4% | 1,380,000 | +16.0% | 1.00% | +7.6% |
Q2 2020 | $28,251,000 | +40.2% | 1,190,000 | +1.7% | 0.92% | +14.8% |
Q1 2020 | $20,147,000 | +13.8% | 1,170,000 | +16.4% | 0.81% | +31.9% |
Q4 2019 | $17,708,000 | -11.0% | 1,005,000 | -10.7% | 0.61% | -16.8% |
Q3 2019 | $19,896,000 | -20.8% | 1,125,000 | -4.3% | 0.73% | -22.0% |
Q2 2019 | $25,110,000 | +7.1% | 1,175,000 | +21.8% | 0.94% | -2.6% |
Q1 2019 | $23,449,000 | +19.2% | 965,000 | -3.5% | 0.97% | -1.7% |
Q4 2018 | $19,670,000 | +16.8% | 1,000,000 | +5.3% | 0.98% | +36.3% |
Q3 2018 | $16,834,000 | +8.6% | 950,000 | +31.9% | 0.72% | +1.1% |
Q2 2018 | $15,494,000 | +70.6% | 720,000 | +75.6% | 0.71% | +64.3% |
Q1 2018 | $9,081,000 | – | 410,000 | – | 0.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |